Search
Login
Register
Menu
BJMO
Home
News
CongressUpdate
Guidelines
Specials
Links
About
Last issue
All issues
Newsletters
Subscribe
Table of Contents:
Neoadjuvant and adjuvant systemic therapy in bladder cancer
How to stage primary prostate cancer in 2022
High-risk prostate carcinoma
What is the role of the patient in the management of prostate cancer?
Renal cell carcinoma
Congress highlights 2022
Read online
All
All
BJMO articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Journal issues
>
Immuno-Oncology special, December 2021
Immuno-Oncology special, December 2021
Immuno-Oncology special, December 2021
Previous issue
Next issue
All issues
Subscribe
Interactive PDF
Quickly to
REVIEW ONCOLOGY
PRACTICE GUIDELINES
PHARMACOTHERAPY
RESEARCH
ONCOCASE
ONCOTHESIS
CONGRESS NEWS
REIMBURSEMENT NEWS
Index
SPECIAL
Integrating immunotherapy in the treatment paradigm for early-stage non-small cell lung cancer
T. Feys
Immune checkpoint inhibition: a game-changer in the treatment of malignant pleural mesothelioma
T. Feys
Immune checkpoint inhibition in kidney transplant recipients
T. Feys, T. Van Meerhaeghe
Immunotherapy for gastro-oesophageal cancers
J. Blokken, T. Feys
The gut microbiome: a predictive biomarker for a response to immune checkpoint inhibition?
T. Feys
Events
Current Month
may, 2022
Evenementen
All
Patient
Specialist
X
